Pasar al contenido principal

IMPLICACION DE LA VIA KINURENINA EN LA DISRUPCION DE LA BARRERA HEMATOENCEFALICA Y SU RELEVANCIA EN LOS EFECTOS AGUDOS Y A LARGO PLAZO INDUCIDOS POR MDMA Y METANFETAMINA

SAF2013-40592-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Disruption of blood–brain barrier integrity in postmortem alcoholic brain: preclinical evidence of TLR4 involvement from a binge-like drinking model

  • Rubio-Araiz, Ana
  • Porcu, Francesca
  • Pérez-Hernández, Mercedes
  • García-Gutiérrez, María Salud
  • Aracil-Fernández, Auxiliadora
  • Gutierrez-López, María Dolores
  • Guerri, Consuelo
  • Manzanares, Jorge
  • O'Shea, Esther
  • Colado, María Isabel
Inflammatory cytokines and reactive oxygen species are reported to be involved in blood–brain barrier (BBB) disruption. Because there is evidence that ethanol (EtOH) induces release of free radicals, cytokines and inflammatory mediators we examined BBB integrity and matrix metalloproteinase (MMP) activity in postmortem human alcoholic brain and investigated the role of TLR4 signaling in BBB permeability in TLR4-knockout mice under a binge-like EtOH drinking protocol. Immunohistochemical studies showed reduced immunoreactivity of the basal lamina protein, collagen-IV and of the tight junction protein, claudin-5 in dorsolateral prefrontal cortex of alcoholics. There was also increased MMP-9 activity and expression of phosphorylated ERK1/2 and p-38. Greater number of CD45+ IR cells were observed associated with an enhanced neuroinflammatory response reflected by increased GFAP and Iba-1 immunostaining. To further explore effects of high EtOH consumption on BBB integrity we studied TLR4-knockout mice exposed to the drinking in the dark paradigm. Repetitive EtOH exposure in wild-type mice decreased hippocampal expression of laminin and collagen-IV and increased IgG immunoreactivity, indicating IgG extravasation. Western blot analysis also revealed increased MyD88 and p-ERK1/2 levels. None of these changes was observed in TLR4-knockout mice. Collectively, these findings indicate that chronic EtOH increases degradation of tight junctions and extracellular matrix in postmortem human brain and induces a neuroinflammatory response associated with activation of ERK1/2 and p-38 and greater MMP-9 activity. The EtOH-induced effects on BBB impairment are not evident in the hippocampus of TLR4-knockout mice, suggesting the involvement of TLR4 signaling in the underlying mechanism leading to BBB disruption in mice., This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (MINECO) (SAF2010-21529 and SAF2013-40592-R to MIC and SAF 2011-23420 to JM), Ministerio de Sanidad, Servicios Sociales e Igualdad (PNSD 2011/043 to JM, PNSD 2013I077 to EOS and PNSD 2014I015 to MIC), ISCIII RETICS RTA (RD06/0001/0006 and RD12/0028/0002 to MIC and RD06/0001/1004 and RD12/0028/0019 to JM), Universidad Complutense (UCM 910258 to MIC) and Consejeria de Educacion y Empleo, Comunidad de Madrid. (CAM S2010-BMD-2308 to MIC). ARA is the recipient of a RETICS RTA post-doctoral contract; MPH and FP are recipients of pre-doctoral fellowships from the Ministerio de Educacion (Spain) and Regione Autonoma Della Sardegna (Italy), respectively., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus

  • Pérez Hernández, Mercedes
  • Gutiérrez López, María Dolores
  • Fernández Valle, María Encarnación
  • Rubio Araiz, Ana
  • Vidal Casado, Rebeca
  • Gutiérrez López, María Dolores
  • O'Shea Gaya, María Esther
  • Colado Megías, María Isabel
The recreational drug of abuse, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier (BBB) integrity in rats through an early P2X7 receptor-mediated event which induces MMP-9 activity. Increased BBB permeability often causes plasma proteins and water to access cerebral tissue leading to vasogenic edema formation. The current study was performed to examine the effect of a single neurotoxic dose of MDMA (12.5 mg/kg, i.p.) on in vivo edema development associated with changes in the expression of the perivascular astrocytic water channel, AQP4, as well as in the expression of the tight-junction (TJ) protein, claudin-5 and Evans Blue dye extravasation in the hippocampus of adult male Dark Agouti rats. We also evaluated the ability of the MMP-9 inhibitor, SB-3CT (25 mg/kg, i.p.), to prevent these changes in order to validate the involvement of MMP-9 activation in MDMA-induced BBB disruption. The results show that MDMA produces edema of short duration temporally associated with changes in AQP4 expression and a reduction in claudin-5 expression, changes which are prevented by SB-3CT. In addition, MDMA induces a short-term increase in both tPA activity and expression, a serine-protease which is involved in BBB disruption and upregulation of MMP-9 expression. In conclusion, this study provides evidence enough to conclude that MDMA induces edema of short duration due to BBB disruption mediated by MMP-9 activation.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor

  • Abuin Martínez, Cristina
  • Vidal Casado, Rebeca
  • Gutiérrez López, María Dolores
  • Pérez Hernández, Mercedes
  • O'Shea Gaya, María Esther
  • Giménez Gómez, Pablo
  • Morales Puerto, Nuria
  • O'Shea Gaya, María Esther
  • Colado Megías, María Isabel
3,4-Methylenedioxymethamphetamine (MDMA) is an amphetamine derivative that has been shown to produce serotonergic damage in the brains of primates, including humans, and of rats. Tryptophan, the precursor of serotonin, is primarily degraded through the kynurenine (KYN) pathway, producing among others KYN, the main metabolite of this route. KYN has been reported as an endogenous agonist of the aryl hydrocarbon receptor (AhR), a transcription factor involved in several neurological functions. This study aims to determine the effect of MDMA on the KYN pathway and on AhR activity and to establish their role in the long-term serotonergic neurotoxicity induced by the drug in rats. Our results show that MDMA induces the activation of the KYN pathway, mediated by hepatic tryptophan 2,3-dioxygenase (TDO). MDMA also activated AhR as evidenced by increased AhR nuclear translocation and CYP1B1 mRNA expression. Autoradiographic quantification of serotonin transporters showed that both the TDO inhibitor 680C91 and the AhR antagonist CH-223191 potentiated the neurotoxicity induced by MDMA, while administration of exogenous l-kynurenine or of the AhR positive modulator 3,3'-diindolylmethane (DIM) partially prevented the serotonergic damage induced by the drug. The results demonstrate for the first time that MDMA increases KYN levels and AhR activity, and these changes appear to play a role in limiting the neurotoxicity induced by the drug. This work provides a better understanding of the physiological mechanisms that attenuate the brain damage induced by MDMA and identify modulation of the KYN pathway and of AhR as potential therapeutic strategies to limit the negative effects of MDMA.